Acquired Immunodeficiency Syndrome With Suspected Early Inflammatory Bowel Disease Diagnosed Following Gastrointestinal Symptoms. [PDF]
Ryu T+4 more
europepmc +1 more source
The Performance of Metagenomic Next-Generation Sequence in the Diagnosis of Suspected Opportunistic Infections in Patients with Acquired Immunodeficiency Syndrome. [PDF]
Liu L+6 more
europepmc +1 more source
LIFE TABLE ANALYSIS OF CHILDREN WITH ACQUIRED IMMUNODEFICIENCY SYNDROME
Rachel Lampert+4 more
openalex +1 more source
Acquired immunodeficiency syndrome-associated T-cell lymphoma: evidence for human immunodeficiency virus type 1-associated T-cell transformation [PDF]
BG Herndier+5 more
openalex +1 more source
Type I interferon signalling and interferon‐responsive microglia in health and disease
Recent insights reveal that type I interferon (IFN‐I) signalling plays critical roles in the nervous system beyond antiviral defence. Dysregulated IFN‐I activity is increasingly linked to neurological dysfunction and neurodegeneration, with microglia as central mediators. This review explores the broader impact of IFN‐I signalling on the nervous system
Jose P. Lopez‐Atalaya+1 more
wiley +1 more source
Disseminated Histoplasmosis-Associated Cardiac Tamponade in a Patient With Acquired Immunodeficiency Syndrome. [PDF]
Ramcharan P+7 more
europepmc +1 more source
Erratum: The Performance of Metagenomic Next-Generation Sequence in the Diagnosis of Suspected Opportunistic Infections in Patients with Acquired Immunodeficiency Syndrome [Corrigendum]. [PDF]
europepmc +1 more source
Acquired immunodeficiency syndrome-related acute longitudinal myelitis involving the entire spinal cord. [PDF]
Zhao Y, Wang F, Cao L.
europepmc +1 more source
A phase 1 study of adoptive transfer of autologous CD8+ T lymphocytes in patients with acquired immunodeficiency syndrome (AIDS)-related complex or AIDS [PDF]
M. Ho+9 more
openalex +1 more source
Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow+3 more
wiley +1 more source